Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

See all formats and pricing


Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Polymorphisms of the β1-adrenergic receptor gene are associated with essential hypertension in Chinese

Yingxin Peng1 / Hao Xue2 / Leiming Luo2 / Wenjing Yao1 / Rongbin Li2

1Cardiac Center, Hebei Provincial People's Hospital, Shijiazhuang, People's Republic of China

2Department of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China

Corresponding author: Hao Xue, Department of Cardiology, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, People's Republic of China Phone: +86 10 66937080, Fax: +86 10 66939751,

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 47, Issue 10, Pages 1227–1231, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2009.276, September 2009

Publication History

Published Online:


Background: The β1-adrenergic receptor (ADRB1) plays a pivotal role in mediating signal transduction of the sympathetic-adrenal system, which is involved in the regulation of cardiac output and peripheral resistance. Our goal was to determine whether the polymorphisms Arg389Gly (rs1801253) and Ser49Gly (rs1801252) of the ADRB1 gene were associated with essential hypertension in Chinese.

Methods: We tested our hypothesis in two independent case-control studies, one comprised 481 patients with hypertension and 529 control subjects, and the other study comprised 212 patients and 325 control subjects. All subjects were genotyped for Arg389Gly and Ser49Gly polymorphisms.

Results: The first study showed that the Arg389Arg genotype of the ADRB1 gene was associated with risk of hypertension [odds ratio (OR) 1.77, 95% confidence interval (CI) 1.09–2.98; p=0.008], and the association was replicated in the second independent population (OR 1.65, 95% CI 1.07–2.89, p=0.01). The patients with the Arg389Arg genotype had significantly higher diastolic blood pressure (DBP) than did those with Arg389Gly genotype as well as those with Gly389Gly genotype (100.29±11.01 mm Hg vs. 95.33±13.10 mm Hg and vs. 96.17±12.18 mm Hg, respectively, p=0.01, p=0.02). The association was replicated in the second study (103.7±13.3 mm Hg vs. 97.31±12.9 mm Hg and vs. 96.29±13.4 mm Hg, respectively, p=0.03, p=0.02). Heart rate also showed an association (in first study: 79.43±9.90 bpm vs. 74.87±8.96 bpm, vs. 73.92±8.18 bpm, respectively, p=0.02, p=0.014; in the second study: 81.12±8.99 bpm vs. 74.85±7.97 bpm and vs. 73.89±9.12 bpm, p=0.007, p=0.006, respectively). No association was seen between systolic blood pressure (SBP) and any of the three genotypes at amino acid position 389 in hypertensive patients, neither between the Ser49Gly polymorphisms and hypertension, nor between the Ser49Gly genotypes and DBP and heart rate.

Conclusions: The polymorphisms of the ADRB1 gene were associated with essential hypertension. The Arg389Gly polymorphism of the ADRB1 gene confers higher risk for hypertension.

Clin Chem Lab Med 2009;47:1227–31.

Keywords: β1-adrenergic receptor; Chinese population; essential hypertension; polymorphism

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Efstratios K. Theofilogiannakos, Konstantinos Dean Boudoulas, Brian E. Gawronski, Taimour Y. Langaee, Timotheos G. Kelpis, Antonios A. Pitsis, Julie A. Johnson, and Harisios Boudoulas
World Journal of Cardiovascular Diseases, 2013, Volume 03, Number 06, Page 406
A. Y. Babenko, E. N. Grineva, D. A. Savitskaja, E. N. Kravchuk, V. N. Solncev, and A. A. Kostareva
BioMed Research International, 2014, Volume 2014, Page 1
Ying Gao, Yahui Lin, Kai Sun, Yibo Wang, Jingzhou Chen, Hu Wang, Xianliang Zhou, Xiaohan Fan, and Rutai Hui
The Journal of Clinical Hypertension, 2014, Volume 16, Number 3, Page 207
Jacob Basson, Jeannette Simino, and D. C. Rao
Current Hypertension Reports, 2012, Volume 14, Number 1, Page 46

Comments (0)

Please log in or register to comment.